MSH6 and neoplasm: Our study is limited by the small size of the study cohort, the lack of matched pre- and post-treatment next-generation sequencing data for 2 of our cases, lack of functional characterization of the MSH6 alteration identified in pTMZ-01, and the unresolved mechanism for the high tumor mutation burden in pTMZ-04.